|
Ajanta Pharma Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
39687.07 Cr.
|
P/BV
|
8.65
|
Book Value (Rs.)
|
367.35
|
|
52 Week High/Low (Rs.)
|
3290/2330
|
FV/ML
|
2/1
|
P/E(X)
|
37.58
|
|
Bookclosure
|
10/11/2025
|
EPS (Rs.)
|
84.54
|
Div Yield (%)
|
0.88
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 5452.86 | 4587.51 | 4161.59 | 3707.52 | 3284.13 |
| Other Operating Revenues | 0.00 | 60.59 | 47.12 | 35.12 | 56.86 |
| Total Operating Revenues | 5452.86 | 4648.10 | 4208.71 | 3742.64 | 3340.99 |
| | | | | | |
| Other Income | 172.07 | 94.50 | 84.60 | 98.64 | 115.68 |
| Total Revenue | 5624.93 | 4742.60 | 4293.31 | 3841.28 | 3456.67 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 916.51 | 846.60 | 939.43 | 878.36 | 779.34 |
| Purchase Of Stock-In Trade | 229.79 | 249.80 | 166.35 | 146.28 | 136.10 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 37.46 | -25.64 | -39.21 | 25.76 | -83.17 |
| Employee Benefit Expenses | 1291.15 | 1089.69 | 900.34 | 785.14 | 645.78 |
| Finance Costs | 16.11 | 20.73 | 7.21 | 5.84 | 10.20 |
| Depreciation And Amortisation Expenses | 173.14 | 144.11 | 135.40 | 130.80 | 125.30 |
| Other Expenses | 1583.12 | 1228.15 | 1069.86 | 1123.85 | 933.64 |
| Total Expenses | 4247.28 | 3553.44 | 3179.38 | 3096.03 | 2547.19 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1377.65 | 1189.16 | 1113.93 | 745.25 | 909.48 |
| | | | | | |
| Profit/Loss Before Tax | 1377.65 | 1189.16 | 1113.93 | 745.25 | 909.48 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 321.65 | 337.28 | 298.22 | 175.58 | 217.22 |
| Deferred Tax | 0.00 | -43.53 | -24.30 | -39.97 | 4.94 |
| Tax For Earlier Years | 0.00 | -24.98 | 23.84 | 21.66 | -25.36 |
| Total Tax Expenses | 321.65 | 268.77 | 297.76 | 157.27 | 196.80 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 1056.00 | 920.39 | 816.17 | 587.98 | 712.68 |
| | | | | | |
| Profit/Loss From Continuing Operations | 1056.00 | 920.39 | 816.17 | 587.98 | 712.68 |
| | | | | | |
| Profit/Loss For The Period | 1056.00 | 920.39 | 816.17 | 587.98 | 712.68 |
| Consolidated Profit/Loss After MI And Associates | 1056.00 | 920.39 | 816.17 | 587.98 | 712.68 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 84.53 | 73.56 | 64.82 | 45.89 | 82.45 |
| Diluted EPS (Rs.) | 84.51 | 73.53 | 64.77 | 45.89 | 82.45 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 349.75 | 642.17 | 89.69 | 82.21 |
